RBC Capital Maintains Outperform on Chemed, Raises Price Target to $604
Chemed Corporation -0.64%
Chemed Corporation CHE | 581.55 | -0.64% |
RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:
CHE) with a Outperform and raises the price target from $576 to $604.
